Karthi20的个人主页 - 老虎社区

Karthi20

Karthi20

暂无个人介绍

IP属地：未知

2关注

6粉丝

0主题

0勋章

2021-11-10

$Bit Digital, Inc.(BTBT)$👍👍

2021-11-03

Patience paid ....💪 $Novavax(NVAX)$. Holding for a months from 136 finally it crossed 200dollar mark

2021-08-14

Like

Biolase Stock Is Trading Higher On Better Than Expected Q2 Earnings<blockquote>Biolase股票因第二季度盈利好于预期而走高</blockquote>

2021-08-14

Yes correct

抱歉，原内容已删除

2021-08-10

😔

抱歉，原内容已删除

2021-08-07

Really????

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4088859564380880","uuid":"4088859564380880","gmtCreate":1625756501313,"gmtModify":1628319094844,"name":"Karthi20","pinyin":"karthi20","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":2,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.51%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.43%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":847785288,"gmtCreate":1636554615280,"gmtModify":1636554615451,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BTBT\">$Bit Digital, Inc.(BTBT)$</a>👍👍","listText":"<a href=\"https://laohu8.com/S/BTBT\">$Bit Digital, Inc.(BTBT)$</a>👍👍","text":"$Bit Digital, Inc.(BTBT)$👍👍","images":[{"img":"https://static.tigerbbs.com/bf8f7ac239c93e832f14592a9c007b09","width":"1125","height":"3943"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847785288","isVote":1,"tweetType":1,"viewCount":792,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":848094450,"gmtCreate":1635947319074,"gmtModify":1635947329208,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"Patience paid ....💪 <a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>. Holding for a months from 136&nbsp;finally&nbsp;it crossed 200dollar mark","listText":"Patience paid ....💪 <a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>. Holding for a months from 136&nbsp;finally&nbsp;it crossed 200dollar mark","text":"Patience paid ....💪 $Novavax(NVAX)$. Holding for a months from 136 finally it crossed 200dollar mark","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/848094450","isVote":1,"tweetType":1,"viewCount":1160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":897339649,"gmtCreate":1628876551081,"gmtModify":1633688807388,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897339649","repostId":"2159021829","repostType":4,"repost":{"id":"2159021829","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1628868159,"share":"https://www.laohu8.com/m/news/2159021829?lang=zh_CN&edition=full","pubTime":"2021-08-13 23:22","market":"us","language":"en","title":"Biolase Stock Is Trading Higher On Better Than Expected Q2 Earnings<blockquote>Biolase股票因第二季度盈利好于预期而走高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2159021829","media":"Benzinga","summary":"\n","content":"<p><ul>  <li><b><a href=\"https://laohu8.com/S/BIOL\">Biolase</a> Inc</b>&nbsp;(NASDAQ:BIOL) shares are trading higher on strong volume after it&nbsp;reported Q2 sales of $9.1 million, +211% Y/Y, edging out a consensus of $8.31 million.</li>  <li>Over 70% of U.S. laser sales came from new customers, continuing a positive trend, and more than 35% of U.S. Waterlase sales came from dental specialists.</li>  <li>Net revenue was 6% higher than the pre-pandemic revenues during the second quarter of 2019.</li>  <li>U.S. and international revenue increased 167% and 340%, respectively, as more dental practices were operating during Q2 than Q2 FY20 due to the pandemic.</li>  <li>Laser system sales increased 424%. Consumables and other revenue increased 173%.</li>  <li>The gross margin expanded to 44% from 32% a year ago due to higher revenue, favorable revenue mix, and higher average selling prices.</li>  <li>During Q2, Biolase was able to break even compared to an EPS loss of $(0.12) a year ago. Cash and cash equivalents totaled $37.1 million.</li>  <li>Biolase forecasts Q3 revenue to be significantly above Q3 FY20 despite the pent-up demand it experienced in last year's Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter.</li>  <li><b>Price Action:</b>&nbsp;BIOL shares are up 31.4% at $0.83 during the market session on the last check Friday.</li> </ul></p><p><blockquote><ul><li><b><a href=\"https://laohu8.com/S/BIOL\">生物酶</a>Inc</b>（纳斯达克：BIOL）公布第二季度销售额为910万美元，同比增长211%，超过市场普遍预期的831万美元，股价因成交量强劲而走高。</li><li>超过70%的美国激光销售额来自新客户，延续了积极的趋势，超过35%的美国Waterlase销售额来自牙科专家。</li><li>2019年第二季度净收入比大流行前高出6%。</li><li>美国和国际收入分别增长了167%和340%，因为受疫情影响，第二季度运营的牙科诊所比2020财年第二季度多。</li><li>激光系统销售额增长424%。耗材及其他收入增长173%。</li><li>由于收入增加、有利的收入组合以及平均售价上涨，毛利率从一年前的32%扩大至44%。</li><li>与一年前每股收益亏损(0.12)美元相比，第二季度Biolase能够实现收支平衡。现金和现金等价物总计3710万美元。</li><li>Biolase预计第三季度收入将显着高于2020财年第三季度，尽管去年第三季度的需求被压抑，因为手术量较2020年第二季度的历史低位大幅改善。</li><li><b>价格走势：</b>周五最后一次检查时，BIOL股价上涨31.4%，至0.83美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biolase Stock Is Trading Higher On Better Than Expected Q2 Earnings<blockquote>Biolase股票因第二季度盈利好于预期而走高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiolase Stock Is Trading Higher On Better Than Expected Q2 Earnings<blockquote>Biolase股票因第二季度盈利好于预期而走高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-08-13 23:22</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><ul>  <li><b><a href=\"https://laohu8.com/S/BIOL\">Biolase</a> Inc</b>&nbsp;(NASDAQ:BIOL) shares are trading higher on strong volume after it&nbsp;reported Q2 sales of $9.1 million, +211% Y/Y, edging out a consensus of $8.31 million.</li>  <li>Over 70% of U.S. laser sales came from new customers, continuing a positive trend, and more than 35% of U.S. Waterlase sales came from dental specialists.</li>  <li>Net revenue was 6% higher than the pre-pandemic revenues during the second quarter of 2019.</li>  <li>U.S. and international revenue increased 167% and 340%, respectively, as more dental practices were operating during Q2 than Q2 FY20 due to the pandemic.</li>  <li>Laser system sales increased 424%. Consumables and other revenue increased 173%.</li>  <li>The gross margin expanded to 44% from 32% a year ago due to higher revenue, favorable revenue mix, and higher average selling prices.</li>  <li>During Q2, Biolase was able to break even compared to an EPS loss of $(0.12) a year ago. Cash and cash equivalents totaled $37.1 million.</li>  <li>Biolase forecasts Q3 revenue to be significantly above Q3 FY20 despite the pent-up demand it experienced in last year's Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter.</li>  <li><b>Price Action:</b>&nbsp;BIOL shares are up 31.4% at $0.83 during the market session on the last check Friday.</li> </ul></p><p><blockquote><ul><li><b><a href=\"https://laohu8.com/S/BIOL\">生物酶</a>Inc</b>（纳斯达克：BIOL）公布第二季度销售额为910万美元，同比增长211%，超过市场普遍预期的831万美元，股价因成交量强劲而走高。</li><li>超过70%的美国激光销售额来自新客户，延续了积极的趋势，超过35%的美国Waterlase销售额来自牙科专家。</li><li>2019年第二季度净收入比大流行前高出6%。</li><li>美国和国际收入分别增长了167%和340%，因为受疫情影响，第二季度运营的牙科诊所比2020财年第二季度多。</li><li>激光系统销售额增长424%。耗材及其他收入增长173%。</li><li>由于收入增加、有利的收入组合以及平均售价上涨，毛利率从一年前的32%扩大至44%。</li><li>与一年前每股收益亏损(0.12)美元相比，第二季度Biolase能够实现收支平衡。现金和现金等价物总计3710万美元。</li><li>Biolase预计第三季度收入将显着高于2020财年第三季度，尽管去年第三季度的需求被压抑，因为手术量较2020年第二季度的历史低位大幅改善。</li><li><b>价格走势：</b>周五最后一次检查时，BIOL股价上涨31.4%，至0.83美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QTWO":"Q2 Holdings Inc","BIOL":"Biolase"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159021829","content_text":"Biolase Inc (NASDAQ:BIOL) shares are trading higher on strong volume after it reported Q2 sales of $9.1 million, +211% Y/Y, edging out a consensus of $8.31 million.\nOver 70% of U.S. laser sales came from new customers, continuing a positive trend, and more than 35% of U.S. Waterlase sales came from dental specialists.\nNet revenue was 6% higher than the pre-pandemic revenues during the second quarter of 2019.\nU.S. and international revenue increased 167% and 340%, respectively, as more dental practices were operating during Q2 than Q2 FY20 due to the pandemic.\nLaser system sales increased 424%. Consumables and other revenue increased 173%.\nThe gross margin expanded to 44% from 32% a year ago due to higher revenue, favorable revenue mix, and higher average selling prices.\nDuring Q2, Biolase was able to break even compared to an EPS loss of $(0.12) a year ago. Cash and cash equivalents totaled $37.1 million.\nBiolase forecasts Q3 revenue to be significantly above Q3 FY20 despite the pent-up demand it experienced in last year's Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter.\nPrice Action: BIOL shares are up 31.4% at $0.83 during the market session on the last check Friday.","news_type":1,"symbols_score_info":{"QTWO":0.9,"BIOL":0.9}},"isVote":1,"tweetType":1,"viewCount":592,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897330760,"gmtCreate":1628876485850,"gmtModify":1633688807736,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"Yes correct","listText":"Yes correct","text":"Yes correct","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/897330760","repostId":"2159657218","repostType":4,"isVote":1,"tweetType":1,"viewCount":825,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892030524,"gmtCreate":1628609360368,"gmtModify":1633745737040,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"😔","listText":"😔","text":"😔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/892030524","repostId":"2158772124","repostType":4,"isVote":1,"tweetType":1,"viewCount":912,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891902787,"gmtCreate":1628313283549,"gmtModify":1633751714442,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"Really????","listText":"Really????","text":"Really????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/891902787","repostId":"1143051031","repostType":4,"isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":848094450,"gmtCreate":1635947319074,"gmtModify":1635947329208,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"Patience paid ....💪 <a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>. Holding for a months from 136&nbsp;finally&nbsp;it crossed 200dollar mark","listText":"Patience paid ....💪 <a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>. Holding for a months from 136&nbsp;finally&nbsp;it crossed 200dollar mark","text":"Patience paid ....💪 $Novavax(NVAX)$. Holding for a months from 136 finally it crossed 200dollar mark","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/848094450","isVote":1,"tweetType":1,"viewCount":1160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":892030524,"gmtCreate":1628609360368,"gmtModify":1633745737040,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"😔","listText":"😔","text":"😔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/892030524","repostId":"2158772124","repostType":4,"isVote":1,"tweetType":1,"viewCount":912,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897339649,"gmtCreate":1628876551081,"gmtModify":1633688807388,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897339649","repostId":"2159021829","repostType":4,"repost":{"id":"2159021829","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1628868159,"share":"https://www.laohu8.com/m/news/2159021829?lang=zh_CN&edition=full","pubTime":"2021-08-13 23:22","market":"us","language":"en","title":"Biolase Stock Is Trading Higher On Better Than Expected Q2 Earnings<blockquote>Biolase股票因第二季度盈利好于预期而走高</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2159021829","media":"Benzinga","summary":"\n","content":"<p><ul>  <li><b><a href=\"https://laohu8.com/S/BIOL\">Biolase</a> Inc</b>&nbsp;(NASDAQ:BIOL) shares are trading higher on strong volume after it&nbsp;reported Q2 sales of $9.1 million, +211% Y/Y, edging out a consensus of $8.31 million.</li>  <li>Over 70% of U.S. laser sales came from new customers, continuing a positive trend, and more than 35% of U.S. Waterlase sales came from dental specialists.</li>  <li>Net revenue was 6% higher than the pre-pandemic revenues during the second quarter of 2019.</li>  <li>U.S. and international revenue increased 167% and 340%, respectively, as more dental practices were operating during Q2 than Q2 FY20 due to the pandemic.</li>  <li>Laser system sales increased 424%. Consumables and other revenue increased 173%.</li>  <li>The gross margin expanded to 44% from 32% a year ago due to higher revenue, favorable revenue mix, and higher average selling prices.</li>  <li>During Q2, Biolase was able to break even compared to an EPS loss of $(0.12) a year ago. Cash and cash equivalents totaled $37.1 million.</li>  <li>Biolase forecasts Q3 revenue to be significantly above Q3 FY20 despite the pent-up demand it experienced in last year's Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter.</li>  <li><b>Price Action:</b>&nbsp;BIOL shares are up 31.4% at $0.83 during the market session on the last check Friday.</li> </ul></p><p><blockquote><ul><li><b><a href=\"https://laohu8.com/S/BIOL\">生物酶</a>Inc</b>（纳斯达克：BIOL）公布第二季度销售额为910万美元，同比增长211%，超过市场普遍预期的831万美元，股价因成交量强劲而走高。</li><li>超过70%的美国激光销售额来自新客户，延续了积极的趋势，超过35%的美国Waterlase销售额来自牙科专家。</li><li>2019年第二季度净收入比大流行前高出6%。</li><li>美国和国际收入分别增长了167%和340%，因为受疫情影响，第二季度运营的牙科诊所比2020财年第二季度多。</li><li>激光系统销售额增长424%。耗材及其他收入增长173%。</li><li>由于收入增加、有利的收入组合以及平均售价上涨，毛利率从一年前的32%扩大至44%。</li><li>与一年前每股收益亏损(0.12)美元相比，第二季度Biolase能够实现收支平衡。现金和现金等价物总计3710万美元。</li><li>Biolase预计第三季度收入将显着高于2020财年第三季度，尽管去年第三季度的需求被压抑，因为手术量较2020年第二季度的历史低位大幅改善。</li><li><b>价格走势：</b>周五最后一次检查时，BIOL股价上涨31.4%，至0.83美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biolase Stock Is Trading Higher On Better Than Expected Q2 Earnings<blockquote>Biolase股票因第二季度盈利好于预期而走高</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiolase Stock Is Trading Higher On Better Than Expected Q2 Earnings<blockquote>Biolase股票因第二季度盈利好于预期而走高</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-08-13 23:22</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><ul>  <li><b><a href=\"https://laohu8.com/S/BIOL\">Biolase</a> Inc</b>&nbsp;(NASDAQ:BIOL) shares are trading higher on strong volume after it&nbsp;reported Q2 sales of $9.1 million, +211% Y/Y, edging out a consensus of $8.31 million.</li>  <li>Over 70% of U.S. laser sales came from new customers, continuing a positive trend, and more than 35% of U.S. Waterlase sales came from dental specialists.</li>  <li>Net revenue was 6% higher than the pre-pandemic revenues during the second quarter of 2019.</li>  <li>U.S. and international revenue increased 167% and 340%, respectively, as more dental practices were operating during Q2 than Q2 FY20 due to the pandemic.</li>  <li>Laser system sales increased 424%. Consumables and other revenue increased 173%.</li>  <li>The gross margin expanded to 44% from 32% a year ago due to higher revenue, favorable revenue mix, and higher average selling prices.</li>  <li>During Q2, Biolase was able to break even compared to an EPS loss of $(0.12) a year ago. Cash and cash equivalents totaled $37.1 million.</li>  <li>Biolase forecasts Q3 revenue to be significantly above Q3 FY20 despite the pent-up demand it experienced in last year's Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter.</li>  <li><b>Price Action:</b>&nbsp;BIOL shares are up 31.4% at $0.83 during the market session on the last check Friday.</li> </ul></p><p><blockquote><ul><li><b><a href=\"https://laohu8.com/S/BIOL\">生物酶</a>Inc</b>（纳斯达克：BIOL）公布第二季度销售额为910万美元，同比增长211%，超过市场普遍预期的831万美元，股价因成交量强劲而走高。</li><li>超过70%的美国激光销售额来自新客户，延续了积极的趋势，超过35%的美国Waterlase销售额来自牙科专家。</li><li>2019年第二季度净收入比大流行前高出6%。</li><li>美国和国际收入分别增长了167%和340%，因为受疫情影响，第二季度运营的牙科诊所比2020财年第二季度多。</li><li>激光系统销售额增长424%。耗材及其他收入增长173%。</li><li>由于收入增加、有利的收入组合以及平均售价上涨，毛利率从一年前的32%扩大至44%。</li><li>与一年前每股收益亏损(0.12)美元相比，第二季度Biolase能够实现收支平衡。现金和现金等价物总计3710万美元。</li><li>Biolase预计第三季度收入将显着高于2020财年第三季度，尽管去年第三季度的需求被压抑，因为手术量较2020年第二季度的历史低位大幅改善。</li><li><b>价格走势：</b>周五最后一次检查时，BIOL股价上涨31.4%，至0.83美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QTWO":"Q2 Holdings Inc","BIOL":"Biolase"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159021829","content_text":"Biolase Inc (NASDAQ:BIOL) shares are trading higher on strong volume after it reported Q2 sales of $9.1 million, +211% Y/Y, edging out a consensus of $8.31 million.\nOver 70% of U.S. laser sales came from new customers, continuing a positive trend, and more than 35% of U.S. Waterlase sales came from dental specialists.\nNet revenue was 6% higher than the pre-pandemic revenues during the second quarter of 2019.\nU.S. and international revenue increased 167% and 340%, respectively, as more dental practices were operating during Q2 than Q2 FY20 due to the pandemic.\nLaser system sales increased 424%. Consumables and other revenue increased 173%.\nThe gross margin expanded to 44% from 32% a year ago due to higher revenue, favorable revenue mix, and higher average selling prices.\nDuring Q2, Biolase was able to break even compared to an EPS loss of $(0.12) a year ago. Cash and cash equivalents totaled $37.1 million.\nBiolase forecasts Q3 revenue to be significantly above Q3 FY20 despite the pent-up demand it experienced in last year's Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter.\nPrice Action: BIOL shares are up 31.4% at $0.83 during the market session on the last check Friday.","news_type":1,"symbols_score_info":{"QTWO":0.9,"BIOL":0.9}},"isVote":1,"tweetType":1,"viewCount":592,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897330760,"gmtCreate":1628876485850,"gmtModify":1633688807736,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"Yes correct","listText":"Yes correct","text":"Yes correct","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/897330760","repostId":"2159657218","repostType":4,"isVote":1,"tweetType":1,"viewCount":825,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891902787,"gmtCreate":1628313283549,"gmtModify":1633751714442,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"Really????","listText":"Really????","text":"Really????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/891902787","repostId":"1143051031","repostType":4,"isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":847785288,"gmtCreate":1636554615280,"gmtModify":1636554615451,"author":{"id":"4088859564380880","authorId":"4088859564380880","name":"Karthi20","avatar":"https://static.tigerbbs.com/3164746cf3c42d87021b4ea804ca9561","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088859564380880","idStr":"4088859564380880"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BTBT\">$Bit Digital, Inc.(BTBT)$</a>👍👍","listText":"<a href=\"https://laohu8.com/S/BTBT\">$Bit Digital, Inc.(BTBT)$</a>👍👍","text":"$Bit Digital, Inc.(BTBT)$👍👍","images":[{"img":"https://static.tigerbbs.com/bf8f7ac239c93e832f14592a9c007b09","width":"1125","height":"3943"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847785288","isVote":1,"tweetType":1,"viewCount":792,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}